NDC 54092-476 – Lialda

Mesalamine 1.2 g/1 · Tablet, Delayed Release · Oral

Human Prescription Drug

Product NDC54092-476

Product details

Brand name
Lialda
Generic name
Mesalamine
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
Tablet, Delayed Release
Route
Oral
Marketing category
NDA · NDA022000
Marketed since
January 16, 2007
Listing expires
December 31, 2027
Pharmacologic class
Aminosalicylate

Active ingredients

Uses, dosage, side effects and warnings for Lialda →

Package NDC codes (4)

Package NDCDescriptionSince
54092-476-01120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-476-01)Jan 16, 2007
54092-476-0212 BOTTLE in 1 CARTON (54092-476-02) / 120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-476-01)Jan 16, 2007
54092-476-083 CARTON in 1 CARTON (54092-476-08) / 8 BLISTER PACK in 1 CARTON / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACKJan 16, 2007
54092-476-12120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-476-12)Jan 16, 2007